Share This Article:

Cellular responding kinetics based on a model of gene regulatory networks under radiotherapy

Abstract Full-Text HTML Download Download as PDF (Size:348KB) PP. 137-146
DOI: 10.4236/health.2010.22021    4,724 Downloads   8,349 Views   Citations

ABSTRACT

Radiotherapy can cause DNA damage into cells, triggering the cell cycle arrest and cell apop-tosis through complicated interactions among vital genes and their signal pathways. In order to in-depth study the complicated cellular res- ponses under such a circumstance, a novel mo- del for P53 stress response networks is pro- posed. It can be successfully used to simulate the dynamic processes of DNA damage trans-ferring, ATM and ARF activation, regulations of P53-MDM2 feedback loop, as well as the toxins degradation. Particularly, it has become feasible to predict the outcomes of cellular response in fighting against genome stresses. Consequently, the new model has provided a reasonable framework for analyzing the complicated regu-lations of P53 stress response networks, as well as investigating the mechanisms of the cellular self-defense under radiotherapy.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Qi, J. , Ding, Y. , Shao, S. , Zeng, X. and Chou, K. (2010) Cellular responding kinetics based on a model of gene regulatory networks under radiotherapy. Health, 2, 137-146. doi: 10.4236/health.2010.22021.

References

[1] Li, L., Story, M. and Legerski, R.J. (2001) Cellular re-sponses to ionizing radiation damage. Int J Radiat Oncol Biol Phys, 49, 1157-1162.
[2] Kohn, K.W. and Pommier, Y. (2005) Molecular interac-tion map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage. Biochem Biophys Res Commun, 331, 816-827.
[3] Perez, C.A. and Purdy, J.A. (1998) Treatment planning in radiation oncology and impact on outcome of therapy. Rays, 23, 385-426.
[4] Tjebbes, G.W., Kreijveld, P.A., Tilanus, M.G., Hordijk, G. J. and Slootweg, P.J. (2002) P53 tumor suppressor gene mutations in laryngeal cancer and in recurrent disease following radiation therapy. Oral Oncol, 38, 296-300.
[5] Duchting, W., Ulmer, W. and Ginsberg, T. (1996) Cancer: a challenge for control theory and computer modelling. Eur J Cancer, 32A, 1283-1292.
[6] Ritter, M.A., Gilchrist, K.W., Voytovich, M., Chappell, R. J. and Verhoven, B.M. (2002) The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys, 53, 574-580.
[7] Lindstrom, M.S. and Wiman, K.G. (2003) Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts. Oncogene, 22, 4993-5005.
[8] Pauklin, S., Kristjuhan, A., Maimets, T. and Jaks, V. (2005) ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress. Biochem Biophys Res Commun, 334, 386-394.
[9] Qi, J.P., Shao, S.H., Li, D.D. and Zhou, G.P. (2007) A dynamic model for the p53 stress response networks under ion radiation. Amino Acids, 33, 75-83.
[10] Qi, J.P., Shao, S.H., Xie, J. and Zhu, Y. (2007) A mathemtical model of P53 gene regulatory networks un-der radiotherapy. Biosystems, 90, 698-706.
[11] Ma, L., Wagner, J., Rice, J.J., Hu, W., Levine, A.J. and Stolovitzky, G.A. (2005) A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci USA, 102, 14266-14271.
[12] Qi, J.P., Shao, S.H. and Shen, Y.Z. (2008) Cellular re-sponding DNA damage: An improved modeling of P53 gene regulatory networks under ion radiation (IR). Ap-plied Mathematics and Computation, 205, 73-83.
[13] Chou, K.C. and Zhou, G.P. (1982) Role of the protein outside active site on the diffusion-controlled reaction of enzyme. Journal of American Chemical Society, 104, 1409-1413.
[14] Chou, K.C. (1988) Review: Low-frequency collective motion in biomacromolecules and its biological functions. Biophysical Chemistry, 30, 3-48.
[15] Chou, K.C. (1989) Graphical rules in steady and non- steady enzyme kinetics. J. Biol. Chem., 264, 12074- 12079.
[16] Chou, K.C. (1990) Review: Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady state systems. Biophysical Chemistry, 35, 1-24.
[17] Ginsberg, T., Ulmer, W. and Duchting, W. (1993) Com-puter simulation of fractionated radiotherapy: further re-sults and their relevance to percutaneous irradiation and brachytherapy. Strahlenther Onkol, 169, 304-310.
[18] Chou, K.C., Kezdy, F.J. and Reusser, F. (1994) Review: Steady-state inhibition kinetics of processive nucleic acid polymerases and nucleases. Analytical Biochemistry, 221, 217-230.
[19] Chou, K.C. (2004) Review: Structural bioinformatics and its impact to biomedical science. Current Medicinal Chemistry, 11, 2105-2134.
[20] Chou, K.C. In Structural bioinformatics and its impact to biomedical science and drug discovery, In: Frontiers in Medicinal Chemistry. Bentham Science Publishers: The Netherlands, 3, 2006.
[21] Huang, R.B., Du, Q.S., Wang, C.H. and Chou, K.C. (2008) An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus. Biochem. Biophys. Res. Comm., 377, 1243-1247.
[22] Chou, K.C. and Shen, H.B. (2008) Cell-PLoc: A package of web-servers for predicting subcellular localization of proteins in various organisms. Nature Protocols, 3, 153-162.
[23] Wang, J.F., Gong, K., Wei, D.Q., Li, Y.X. and Chou, K.C. (2009) Molecular dynamics studies on the interactions of PTP1B with inhibitors: From the first phosphate binding site to the second one. Protein Engineering Design and Selection, 22, 349-355.
[24] Althaus, I.W., Chou, J.J., Gonzales, A.J., Diebel, M.R., Chou, K.C., Kezdy, F.J., Romero, D.L., Aristoff, P.A., Tarpley, W.G. and Reusser, F. (1993) Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcrip-tase inhibitor U-87201E. J. Biol. Chem., 268, 6119-6124.
[25] Althaus, I.W., Gonzales, A.J., Chou, J.J., Diebel, M.R., Chou, K.C., Kezdy, F.J., Romero, D.L., Aristoff, P.A., Tarpley, W.G. and Reusser, F. (1993) The quinoline U- 78036 is a potent inhibitor of HIV-1 reverse transcriptase. J. Biol. Chem., 268, 14875-14880.
[26] Althaus, I.W., Chou, J.J., Gonzales, A.J., Diebel, M.R., Chou, K.C., Kezdy, F.J., Romero, D.L., Aristoff, P.A., Tarpley, W.G. and Reusser, F. (1993) Kinetic studies with the nonnucleoside HIV-1 reverse transcriptase inhibitor U-88204E. Biochemistry, 32, 6548-6554.
[27] Chou, K.C., Wei, D.Q. and Zhong, W.Z. (2003) Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. (Erratum: ibid., 2003, Vol.310, 675). Biochem Biophys Res Comm, 308, 148-151.
[28] Du, Q.S., Wang, S.Q., Jiang, Z.Q., Gao, W.N., Li, Y.D., Wei, D.Q. and Chou, K.C. (2005) Application of bioin-formatics in search for cleavable peptides of SARS-CoV Mpro and chemical modification of octapeptides. Me-dicinal Chemistry, 1, 209-213.
[29] Zhang, R., Wei, D.Q., Du, Q.S. and Chou, K.C. (2006) Molecular modeling studies of peptide drug candidates against SARS. Medicinal Chemistry, 2, 309-314.
[30] Du, Q.S., Sun, H. and Chou, K.C. (2007) Inhibitor design for SARS coronavirus main protease based on “distorted key theory”. Medicinal Chemistry, 3, 1-6.
[31] Zheng, H., Wei, D.Q., Zhang, R., Wang, C., Wei, H. and Chou, K.C. (2007) Screening for new agonists against Alzheimer's disease. Medicinal Chemistry, 3, 488-493.
[32] Wei, H., Wang, C.H., Du, Q.S., Meng, J. and Chou, K.C. (2009) Investigation into adamantane-based M2 inhibitors with FB-QSAR. Medicinal Chemistry, 5, 305-317.
[33] Gong, K., Li, L., Wang, J.F., Cheng, F., Wei, D.Q. and Chou, K.C. (2009) Binding mechanism of H5N1 influ-enza virus neuraminidase with ligands and its implication for drug design. Medicinal Chemistry, 5, 242-249.
[34] Chou, K.C. (1987) The biological functions of low- fre-quency phonons: 6. A possible dynamic mechanism of allosteric transition in antibody molecules. Biopolymers, 26, 285-295.
[35] Chou, K.C. (1989) Low-frequency resonance and coop-erativity of hemoglobin. Trends in Biochemical Sciences, 14, 212.
[36] Schnell, J.R. and Chou, J.J. (2008) Structure and mecha-nism of the M2 proton channel of influenza A virus. Na-ture, 451, 591-595.
[37] Gordon, G. (2008) Extrinsic electromagnetic fields, low frequency (phonon) vibrations, and control of cell func-tion: a non-linear resonance system. Journal of Biomedi- cal Science and Engineering (JBiSE), 1, 152-156 (open accessible at http://www.srpublishing.org/journal/jbise/).
[38] Du, Q.S., Huang, R.B., Wang, C.H., Li, X.M. and Chou, K. C. (2009) Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza. A virus Journal of Theoretical Biology, 259, 159-164.
[39] Pielak, R.M., Jason, R., Schnell, J.R. and Chou, J.J. (2009) Mechanism of drug inhibition and drug resistance of in-fluenza A M2 channel. Proceedings of National Academy of Science, USA, 106, 7379-7384.
[40] Chou, K.C. and Jiang, S.P. (1974) Studies on the rate of diffusion-controlled reactions of enzymes. Scientia Sinica, 17, 664-680.
[41] Chou, K.C. (1984) The biological functions of low- fre-quency phonons: 3. Helical structures and microenvi-ronment. Biophysical Journal, 45, 881-890.
[42] Chou, K.C., Kiang, Y.S. (1985) The biological functions of low-frequency phonons: 5. A phenomenological theory. Biophysical Chemistry, 22, 219-235.
[43] Zhou, G.P. (1989) Biological functions of soliton and extra electron motion in DNA structure. Physica Scripta, 40, 698-701.
[44] Chou, K.C., Maggiora, G.M., Mao, B. (1989) Quasi- continuum models of twist-like and accordion-like low- frequency motions in DNA. Biophysical Journal, 56, 295-305.
[45] Chou, K.C., Zhang, C.T., Maggiora, G.M. (1994) Solitary wave dynamics as a mechanism for explaining the internal motion during microtubule growth. Biopolymers, 34, 143-153.
[46] Sinkala, Z. (2006) Soliton/exciton transport in proteins. J Theor Biol, 241, 919-927.
[47] Chou, K.C. and Shen, H.B. (2009) FoldRate: A web- server for predicting protein folding rates from primary sequence. The Open Bioinformatics Journal, 3, 31-50 (openly acces-sible at http://www.bentham.org/open/tobioij/).
[48] Shen, H.B., Song, J.N. and Chou, K.C. (2009) Prediction of protein folding rates from primary sequence by fusing multiple sequential features. Journal of Biomedical Sci-ence and Engineering (JBiSE), 2, 136-143 (openly ac-cessible at http://www.srpublishing.org/journal/jbise/).
[49] Chou, K.C. and Zhang, C.T. (1992) Diagrammatization of codon usage in 339 HIV proteins and its biological im-plication AIDS. Research and Human Retroviruses, 8, 1967-1976.
[50] Zhang, C.T. and Chou, K.C. (1994) Analysis of codon usage in 1562 E. Coli protein coding sequences. Journal of Molecular Biology, 238, 1-8.
[51] Zhang, C.T. and Chou, K.C. (1996) An analysis of base frequencies in the anti-sense strands corresponding to the 180 human protein coding sequences. Amino Acids, 10, 253-262.
[52] Xiao, X., Shao, S.H. and Chou, K.C. (2006) A probability cellular automaton model for hepatitis B viral infections. Biochem. Biophys. Res. Comm., 342, 605-610.
[53] Xiao, X., Shao, S., Ding, Y., Huang, Z., Chen, X. and Chou, K.C. (2005) An Application of Gene Comparative Image for Predicting the Effect on Replication Ratio by HBV Virus Gene Missense Mutation. Journal of Theo-retical Biology, 235, 555-565.
[54] Xiao, X., Wang, P. and Chou, K.C. (2009) GPCR-CA: A cellular automaton image approach for predicting G- protein-coupled receptor functional classes. Journal of Computational Chemistry, 30, 1414-1423.
[55] Xiao, X., Shao, S.H., Ding, Y.S., Huang, Z.D. and Chou, K.C. (2006) Using cellular automata images and pseudo amino acid composition to predict protein subcellular lo-cation. Amino Acids, 30, 49-54.
[56] Wang, M., Yao, J.S., Huang, Z.D., Xu, Z.J., Liu, G.P., Zhao, H.Y., Wang, X.Y., Yang, J., Zhu, Y.S. and Chou, K. C. (2005) A new nucleotide-composition based finger-print of SARS-CoV with visualization analysis. Medicinal Chemistry, 1, 39-47.
[57] Gao, L., Ding, Y.S., Dai, H., Shao, S.H., Huang, Z.D. and Chou, K.C. (2006) A novel fingerprint map for detecting SARS-CoV. Journal of Pharmaceutical and Biomedical Analysis, 41, 246-250.
[58] Tyson, J.J. (1999) Models of cell cycle control in eu-karyotes. J Biotechnol, 71, 239-244.
[59] Tyson, J.J. and Novak, B. (2001) Regulation of the eu-karyotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J Theor Biol, 210, 249-263.
[60] Magne, N., Toillon, R.A., Bottero, V., Didelot, C., Houtte, P.V., Gerard, J.P. and Peyron, J.F. (2006) NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett, 231, 158-168.
[61] Chou, K.C., Watenpaugh, K.D. and Heinrikson, R.L. (1999) A Model of the complex between cyclin- de-pendent kinase 5 (Cdk5) and the activation domain of neuronal Cdk5 activator. Biochemical & Biophysical Re-search Communications, 259, 420-428.
[62] Rapp, A. and Greulich, K.O. (2004) After double-strand break induction by UV-A, homologous recombination and nonhomologous end joining cooperate at the same DSB if both systems are available. J Cell Sci, 117, 4935-4945.
[63] Rothkamm, K., Kruger, I., Thompson, L.H. and Lobrich, M. (2003) Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol, 23, 5706-5715.
[64] Budman, J. and Chu, G. (2005) Processing of DNA for nonhomologous end-joining by cell-free extract. EMBO J, 24, 849-860.
[65] Daboussi, F., Dumay, A., Delacote, F. and Lopez, B.S. (2002) DNA double-strand break repair signalling: the case of RAD51 post-translational regulation. Cell Signal, 14, 969-975.
[66] Oren, M. (2003) Decision making by p53: Life, death and cancer. Cell Death Differ, 10, 431-442.
[67] Lev Bar-Or, R., Maya, R., Segel, L.A., Alon, U., Levine, A.J. and Oren, M. (2000) Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A, 97, 11250-11255.
[68] Weller, M. (199) Predicting response to cancer chemo-therapy: the role of p53. Cell Tissue Res, 292, 435-445.
[69] Lahav, G., Rosenfeld, N., Sigal, A., Geva-Zatorsky, N., Levine, A.J., Elowitz, M.B. and Alon, U. (2004) Dynam-ics of the p53-Mdm2 feedback loop in individual cells. Nat Genet, 36, 147-150.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.